Tanjian Future Secures Tens of Millions in Series A+ Funding to Accelerate Construction of Digital-Intelligent Innovation Industry Service Platform

VCBeat has learned that “Tanjian Future” recently completed a tens-of-millions-level Series A+ financing round, led byGUANDA HOLDING GROUPandShouyi Sci-Tech Innovation Fund of FundsJoint investment, with the funds to be used to accelerate the construction of the enterprise’s digital-intelligence innovation industry service system, market expansion, and the development of professional service teams.

Tanjian Future was established in 2017, evolving from “Probe Capital,” a leading boutique investment bank in China’s healthcare sector, andCompleted Series A financing in early 2024Leveraging the data capabilities of its self-developed industrial data platform, “Shennong No. 1,” the “Probe Capital” service brand has been officially upgraded to“Tanjian Future”, from its origins as a boutique investment bank dedicated to helping scientists and entrepreneurs drive medical progress, it has continuously expanded its business boundaries, gradually building a comprehensive suite of services includingCorporate Financial Advisory, Industrial Investment Promotion and Operations, Equity Investmentand other multi-dimensional servicesOne-Stop Innovation Industry Service Platform.

Since its inception, Probes Capital has completed double-digit private equity financing and M&A transactions annually, with a cumulative transaction volume amounting to tens of billions of RMB. Embracing the trend of digital transformation in the industry, Probes Capital officially launched its self-developed industrial data platform, “Shennong No. 1,” in 2022.

Under the new normal of primary market investment and financing, there has been a significant adjustment in the structure of capital supply. The proportion of state-owned capital contributions has increased, accompanied by more active deal-making. By covering data from over 20,000 investment institutions, Probe Capital dynamically tracks the investment strategies and portfolio directions of more than 3,000 active life sciences institutions in China, thereby transforming the traditional boutique investment bank model that relied solely on network-based intelligence gathering and analysis.

With the completion of this round of financing, the granularity of the industrial data platform continues to be refined, and its intelligent analytical capabilities will be further enhanced. In the future, within investment and financing transactions, Tanjian will not only optimize the efficiency of capital allocation but also improve the financing efficiency of innovative enterprises from a holistic perspective, thereby accelerating the translation of scientific and technological achievements into industrial applications.

Currently, across China, the focus is on cultivating and developing new quality productive forces. Regional governments are continuously clarifying and refining their industrial development plans based on local industrial foundations and locational resource advantages. How to achieve superior outcomes in fiercely competitive investment promotion through differentiated industrial positioning and precise supply chain-oriented investment attraction has become the optimal solution.

Leveraging the “Shennong No. 1” industry data platform, Probe Capital has accurately and clearly mapped out the full landscape of industry dynamics by covering nearly 1,000 subsectors in the life sciences field and approximately 100,000 innovative enterprises worldwide. Currently, Probe Capital has established business collaborations with governments and industrial carriers in the Yangtze River Delta, Sichuan-Chongqing, and Beijing-Tianjin-Hebei regions, facilitating the local establishment of a cohort of innovative enterprises through its capital operations and industrial ecosystem services.

In the future, “Shennong No. 1” will demonstrate enhanced data insight capabilities within Probe Capital’s operations. In the context of translating scientific and technological achievements into practical applications, it will assess industrialization potential using a comprehensive set of quantitative metrics. In industrial investment decision-making scenarios, it will enable comprehensive scanning and dynamic evaluation of market sectors. In industrial investment promotion scenarios, it will precisely generate targeted roadmaps for attracting investments in specific sub-sectors and fields. Leveraging its multi-layered industrial ecosystem network, Probe Capital will be able to reach innovative enterprises through diverse channels, helping them find fertile ground for growth and development while further empowering the quality improvement and accelerated growth of regional industrial clusters.

As a strategic emerging industry, the bio-manufacturing sector, underpinned by synthetic biology technologies, is experiencing a surge in momentum. Across multiple industrial scenarios—including biopharmaceuticals, food, agriculture, materials, energy, and chemical engineering—innovative synthetic biology solutions are transforming production paradigms. To date, Probes Capital has invested in several synthetic biology projects, including Enzyme Biotech and Qicai Shuxin, and has facilitated nearly RMB 500 million in financing for more than ten synthetic biology enterprises.

The biomanufacturing industry is entering a critical period of breakthrough development. As one of its key focus areas, Probes Capital will anchor itself in the scenarios and demands of biomanufacturing, dynamically tracking the development trends of over 500 synthetic biology innovators. It will actively provide industry insights, data, and professional services to various stakeholders, including listed companies, industrial conglomerates, investment institutions, regional governments, and spatial carriers. By linking the innovation chain, supply chain, and industrial chain, Probes Capital aims to foster integration and mutual success among all parties within its ecosystem network.

For this round of financing,Yan Jingjing, Founding Partner of Tanjian Futurestated: “With the joining and support of more industrial shareholders, we are confident in fully leveraging our data-driven capital operation and industrial service advantages during the process of strengthening emerging industries, cultivating future industries, and revitalizing traditional industries. We aim to help more scientists and entrepreneurs achieve the commercialization of scientific and technological achievements and accelerate industrialization, assist regional governments in accelerating industrial upgrading and clustering, and hasten the formation of new quality productive forces, thereby promoting the development of related niche industries.”